Membrane Transport and Drug Targeting Laboratory, Graduate School of Pharmaceutical Sciences (M.T., Y.S., K.S., M.W., Y.U., T.T.), and Department of Integrative Genomics, Tohoku Medical Megabank Organization (D.S.), Tohoku University, Sendai, Japan
Membrane Transport and Drug Targeting Laboratory, Graduate School of Pharmaceutical Sciences (M.T., Y.S., K.S., M.W., Y.U., T.T.), and Department of Integrative Genomics, Tohoku Medical Megabank Organization (D.S.), Tohoku University, Sendai, Japan.
Drug Metab Dispos. 2018 May;46(5):610-618. doi: 10.1124/dmd.117.079244. Epub 2018 Mar 5.
The purpose of the present study was to clarify the molecular basis of zonated drug distributions in mouse liver based on the protein expression levels of transporters and metabolizing enzymes in periportal (PP) and pericentral (PC) vein regions of mouse hepatic lobules. The distributions of sulforhodamine 101 (SR-101), a substrate of organic anion transporting polypeptides (Oatps), and ribavirin, a substrate of equilibrative nucleoside transporter 1 (Ent1), were elucidated in frozen liver sections of mice, to which each compound had been intravenously administered. Regions strongly positive for SR-101 (SR-101) and regions weakly positive or negative for SR-101 (SR-101) were separated by laser microdissection. The zonated distribution of protein expression was quantified in terms of the liver zonation index. Quantitative targeted absolute proteomics revealed the selective expression of glutamine synthetase in the SR-101 region, indicating predominant distribution of SR-101 in hepatocytes of the PC vein region. The protein levels of Oatp1a1, Oatp1b2, organic cation transporter 1 (Oct1), and cytochrome P450 (P450) 2e1 were greater in the PC vein regions, whereas the level of organic anion transporter 2 (Oat2) was greater in the PP vein regions. Mouse Oatp1a1 mediated SR-101 transport. On the other hand, there were no statistically significant differences in expression of Ent1, Na-taurocholate cotransporting polypeptide, several canalicular transporters, P450 enzymes, and UDP-glucuronosyltransferases between the PP and PC vein regions. This is consistent with the almost uniform distribution of ribavirin in the liver. In conclusion, sinusoidal membrane transporters such as Oatp1a1, Oatp1b2, Oct1, and Oat2 appear to be determinants of the zonated distribution of drugs in the liver.
本研究旨在基于有机阴离子转运多肽(Oatps)的底物磺罗丹明 101(SR-101)和核苷转运蛋白 1(Ent1)的底物利巴韦林在小鼠肝小叶门静脉区(PP)和中央静脉区(PC)的蛋白表达水平,阐明小鼠肝内药物分区分布的分子基础。通过向小鼠静脉内给予每种化合物,在冷冻的肝切片中阐明了磺罗丹明 101(SR-101)和利巴韦林的分布。通过激光微切割将强烈阳性的 SR-101 区域(SR-101)和弱阳性或阴性的 SR-101 区域(SR-101)分开。采用肝分区指数定量分析蛋白表达的分区分布。定量靶向绝对蛋白质组学揭示了谷氨酰胺合成酶在 SR-101 区域的选择性表达,表明 SR-101 主要分布在 PC 静脉区的肝细胞中。Oatp1a1、Oatp1b2、有机阳离子转运蛋白 1(Oct1)和细胞色素 P450(P450)2e1 的蛋白水平在 PC 静脉区更高,而有机阴离子转运蛋白 2(Oat2)的蛋白水平在 PP 静脉区更高。小鼠 Oatp1a1 介导 SR-101 转运。另一方面,在 PP 和 PC 静脉区之间,Ent1、牛磺胆酸钠共转运蛋白、几种胆小管转运蛋白、P450 酶和 UDP-葡糖醛酸基转移酶的表达没有统计学上的显著差异。这与利巴韦林在肝脏中的几乎均匀分布一致。总之,Oatp1a1、Oatp1b2、Oct1 和 Oat2 等窦状膜转运蛋白似乎是药物在肝脏中分区分布的决定因素。